Functional heterogeneity of prostatic intraepithelial neoplasia: The duration of hormonal therapy influences the response

BJU International

Volumn 99, Issue 5, 2007, Pages 1024-1027

  Kang, Tyler Y ^a,b   Nichols, Peter ^b   Skinner, Eila ^b   Groshen, Susan ^b   Valin, Greg ^b   Ye, Wei ^b   Raghavan, Derek ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Androgen deprivation; Hormone therapy; Prostate cancer; Prostatic intraepithelial neoplasia

Indexed keywords

BICALUTAMIDE; GONADORELIN AGONIST;

ADULT; ARTICLE; CANCER HORMONE THERAPY; CANCER SURGERY; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PATHOLOGIST; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGEON; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR BIOPSY;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; COHORT STUDIES; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 34247131222     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06738.x     Document Type: Article

References (16)

1. Oerteil H. Involutionary changes in prostate and female breast in relation to cancer development. Can Med Assoc J 1926; 16: 237-41
2. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987; 59: 788-94
3. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986; 17: 64-71
4. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993; 150: 379-85
5. Sakr WA, Grignon DJ, Crissman JD et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994; 8: 439-43
6. Bostwick DG. Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 1996; 30: 145-52
7. van der Kwast TH, Tetu B. Androgen receptors in untreated and treated prostatic intraepithelial neoplasia. Eur Urol 1996; 30: 265-8
8. Trapman J, Brinkmann AO. The androgen receptor in prostate cancer. Pathol Res Pract 1996; 192: 752-60
9. Balaji KC, Rabbani F, Tsai H, Bastar A, Fair WR. Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance. J Urol 1999; 162: 753-7
10. Cote RJ, Skinner EC, Salem CE et al. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. Br J Cancer 1998; 78: 413-8
11. Thompson IM, Goodmen PJ, Tangen CM et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349: 215-24
12. Bostwick DG, Qian J. Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia. Urology 2001; 58 (Suppl. 1): 91-3
13. Alberts SR, Blute ML. Chemoprevention for prostatic carcinoma. the role of flutamide in patients with prostatic intraepithelial neoplasia. Urology 2001; 57 (Suppl. 1): 188-90
14. Meng MV, Shinohara K, Grossfeld GD. Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy. Urol Oncol 2003; 21: 145-51
15. Epstein JI, Grignon DJ, Humphrey PA et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995; 19: 873-86
16. Allam CK, Bostwick DG, Hayes JA et al. Interobserver variability in the diagnosis of high grade prostatic intraepithelial neoplasia and adnocarcinoma. Mod Pathol 1996; 9: 742-51